ViewMind

ViewMind is rated 3 out of 5 in the category medical devices. Read and write reviews about ViewMind. ViewMind is a science-based company specialized in the development of neurocognitive assessment evaluations. Using Eye-Tracking technology, in a 5 minutes, non-invasive and completely automatized test, we are able to detect Mild Cognitive Impairment and to predict the onset of Alzheimer's Disease, up to 6 years in advance, with 98% of specificity. With our own patented and continuously improving algorithms, we can quantify the cognitive performance of a person, analyzing executive, attentional and memory functions and detecting minor changes on their performance through short periods of time. In collaboration with Heriot Watt University, ViewMind is developing an Alzheimer’s Disease Biomarker with the goal of predicting the onset of the pathology with more than a decade of anticipation. Additionally, ViewMind is able to evaluate and quantify cognitive functions in persons affected by a number of different psychiatric and neurological pathologies (i.e. Multiple Sclerosis, Depression, Schizophrenia, Parkinson, etc.), measuring with accuracy the impact of treatments on them. With a wide range of neurocognitive batteries, ViewMind will assist pharmaceutical companies on the development of new drugs for multiple neurocognitive and neurodegenerative diseases.